The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Open accessAbstract
It is widely accepted that reactive oxygen species (ROS) promote tumorigenesis. However, the exact mechanisms are still unclear. As mice lacking the peroxidase peroxiredoxin1 (Prdx1) produce more cellular ROS and die prematurely of cancer, they offer an ideal model system to study ROS-induced tumorigenesis. Prdx1 ablation increased the susceptibility to Ras-induced breast cancer. We, therefore, investigated the role of Prdx1 in regulating oncogenic Ras effector pathways. We found Akt hyperactive in fibroblasts and mammary epithelial cells lacking Prdx1. Investigating the nature of such elevated Akt activation established a novel role for Prdx1 as a safeguard for the lipid phosphatase activity of PTEN, which is essential for its tumour suppressive function. We found binding of the peroxidase Prdx1 to PTEN essential for protecting PTEN from oxidation-induced inactivation. Along those lines, Prdx1 tumour suppression of Ras- or ErbB-2-induced transformation was mediated mainly via PTEN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, W., Zhu, T., & Guan, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405730200 · Cited by 77
RetractedSWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
H 2 O 2 , a Necessary Evil for Cell Signaling
Rhee, S. G. (2006) · Science · doi:10.1126/science.1130481 · Cited by 2,160
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067
Self-citationReversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,057
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Thioredoxin-dependent peroxide reductase from yeast.
Chae, H. Z., Chung, S. J., & Rhee, S. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47038-x · Cited by 957
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801
Self-citationSinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Kwon, J., Lee, S.-R., Yang, K.-S., Ahn, Y., Kim, Y. J., Stadtman, E. R., & Rhee, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407396101 · Cited by 631
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
Leslie, N. R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg513 · Cited by 616
Self-citationEnumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612
Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M., & Sellers, W. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2110 · Cited by 575
Ho, Y.-S., Magnenat, J.-L., Bronson, R. T., Cao, J., Gargano, M., Sugawara, M., & Funk, C. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16644 · Cited by 562
Self-citationYang, K.-S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206626200 · Cited by 458
The role of PTEN signaling perturbations in cancer and in targeted therapy
Keniry, M., & Parsons, R. (2008) · Oncogene · doi:10.1038/onc.2008.248 · Cited by 358
Membrane-binding and activation mechanism of PTEN
Das, S., Dixon, J. E., & Cho, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932835100 · Cited by 335
Dimerization of thiol-specific antioxidant and the essential role of cysteine 47.
Chae, H. Z., Uhm, T. B., & Rhee, S. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7022 · Cited by 309
Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7Å resolution
Schröder, E., Littlechil*, J. A., Lebedev, A. A., Errington, N., Vagin, A. A., & Isupov, M. N. (2000) · Structure · doi:10.1016/s0969-2126(00)00147-7 · Cited by 297
Zhang, Z. Y., & Dixon, J. E. (1993) · Biochemistry · doi:10.1021/bi00087a012 · Cited by 273
Wen, S.-T., & Van Etten, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 265
Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3465 · Cited by 251
Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid
Woo, H. A., Won Kang, S., Kim, H. K., Yang, K.-S., Chae, H. Z., & Rhee, S. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300428200 · Cited by 241
The deficiency of Akt1 is sufficient to suppress tumor development in Pten +/− mice
Chen, M.-L., Xu, P.-Z., Peng, X., Chen, W. S., Guzman, G., Yang, X., Di Cristofano, A., Pandolfi, P. P., & Hay, N. (2006) · Genes & Development · doi:10.1101/gad.1395006 · Cited by 241
Maroulakou, I. G., Oemler, W., Naber, S. P., & Tsichlis, P. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3782 · Cited by 238
Skeen, J. E., Bhaskar, P. T., Chen, C.-C., Chen, W. S., Peng, X.-D., Nogueira, V., Hahn-Windgassen, A., Kiyokawa, H., & Hay, N. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.022 · Cited by 234
Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1
Egler, R. A., Fernandes, E., Rothermund, K., Sereika, S., de Souza-Pinto, N., Jaruga, P., Dizdaroglu, M., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208821 · Cited by 231
Meuillet, E. J., Mahadevan, D., Berggren, M., Coon, A., & Powis, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.020 · Cited by 192
Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane
Vazquez, F., Matsuoka, S., Sellers, W. R., Yanagida, T., Ueda, M., & Devreotes, P. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510570103 · Cited by 188
Kim, Y.-J., Lee, W.-S., Ip, C. C. Y., Chae, H., Park, E., & Park, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4446 · Cited by 165
Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation
Rao, R. K., & Clayton, L. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00268-1 · Cited by 164
Lim, K.-H., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.014 · Cited by 159
The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival
Schwartzbauer, G., & Robbins, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102479200 · Cited by 142
Are peroxiredoxins tumor suppressors?
Neumann, C. A., & Fang, Q. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.007 · Cited by 133
Self-citationAkt/PKB Activity Is Required for Ha-Ras-mediated Transformation of Intestinal Epithelial Cells
Sheng, H., Shao, J., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010093200 · Cited by 108
Electrostatic Evaluation of the Signature Motif (H/V)CX5R(S/T) in Protein−Tyrosine Phosphatases
Peters, G. H. J., Frimurer, T. M., & Olsen, O. H. (1998) · Biochemistry · doi:10.1021/bi971187i · Cited by 107
Leslie, N. R., Alex, G. R. A. Y., Pass, I., Orchiston, E. A., & Downes, C. P. (2000) · Biochemical Journal · doi:10.1042/bj3460827 · Cited by 74
Self-citationDimer-Oligomer Interconversion of Wild-type and Mutant Rat 2-Cys Peroxiredoxin
Matsumura, T., Okamoto, K., Iwahara, S.-I., Hori, H., Takahashi, Y., Nishino, T., & Abe, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705753200 · Cited by 70
Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene
Tolkacheva, T., & Chan, A. M.-L. (2000) · Oncogene · doi:10.1038/sj.onc.1203331 · Cited by 64
Koul, D., Jasser, S. A., Lu, Y., Davies, M. A., Shen, R., Shi, Y., Mills, G. B., & Yung, W. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205296 · Cited by 55
A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in Macrophages
Pasquali, C., Bertschy‐Meier, D., Chabert, C., Curchod, M., Arod, C. Y., Booth, R., Mechtler, K., Vilbois, F., Xénarios, I., Ferguson, C. G., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600066-mcp200 · Cited by 38
Cited by
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
“Since this PRX1 inactivation is localized to membranes it allows intracellular PRX1 pools to remain active, thus preventing peroxide build up in the cells.”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
“At low levels, ROS increase cell proliferation and survival through the post-translational modification of kinases and phosphatase”
BackgroundSignal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322
“Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.”
BackgroundInfluentialThe functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Metadata
- Authors
- Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., Manevich, Y., Beeson, C., & Neumann, C. A.
- Venue
- The EMBO Journal
- Published
- 2009-04-16
- Volume
- 28
- Issue
- 10
- Pages
- 1505-1517
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2005478135
- Cited by
- 344
- References
- 44
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.